HIV enters the brain and doesn't leave, drugs intended to reduce brain inflammation increase virus levels
HIV can damage the brain and cause memory and cognitive problems. And once HIV enters the brain, it does not leave.
Jun 8, 2026
0
4
Amino Acids, Peptides, and Proteins: News and Research on Natalizumab
MeSH tree: D12.776.377.715.548.114.224.200.813
Machine learning and cell imaging combine to predict effectiveness of multiple sclerosis medication
Brazilian researchers, in partnership with French institutions, have developed a tool that can predict how patients will respond to natalizumab, one of the most commonly used drugs for treating multiple sclerosis.
Sep 25, 2025
0
23
Multi-registry study highlights ocrelizumab's superior relapse control in multiple sclerosis
New research presented at the 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS 2025) demonstrates that ocrelizumab provides superior control of multiple sclerosis (MS) relapses ...
Sep 23, 2025
0
15
Simple algorithm helps improve treatment, reduce racial disparities for patients with multiple sclerosis
A simple treatment algorithm may help reduce treatment disparities for Hispanic and Black people with multiple sclerosis (MS), according to a preliminary study released today, March 3, 2025, that will be presented at the ...
Mar 3, 2025
0
11
Early treatment significantly reduces long-term disability in children with multiple sclerosis, new study finds
New research presented today at European Committee for Treatment and Research in Multiple Sclerosis 2024 reveals that initiating monoclonal antibody therapy during childhood, rather than delaying treatment until early adulthood, ...
Sep 17, 2024
0
49
Scientists aim to understand why men with prostate cancer are at higher risk of Alzheimer's
Researchers at the Medical College of Georgia at Augusta University are searching for a better way to understand why many men with prostate cancer end up with Alzheimer's disease, and whether it's the standard hormone therapy ...
Aug 29, 2024
0
67
Study finds MS drugs taken while breastfeeding may not affect child development
Certain medications for multiple sclerosis (MS) called monoclonal antibodies, taken while breastfeeding, may not affect the development of a child during the first three years of life, according to a preliminary study presenting ...
Mar 4, 2024
0
32
Mouse study yields potential new target to combat multiple sclerosis
Researchers at Duke University School of Medicine, studying multiple sclerosis (MS) in mice, identified a protein that could reshape the understanding of MS treatments.
Oct 16, 2023
0
51
New study reduces risks associated with switching MS medication
A best treatment pathway has been identified for people with multiple sclerosis (MS) whose current medication puts them at risk of a serious brain infection.
Jun 5, 2023
0
52
Leading MS/PML experts recommend genetic testing to prevent fatal brain infection stemming from medication
In an editorial in the journal Frontiers in Neurology, two leading multiple sclerosis (MS) experts are advocating for genetic testing to identify MS patients who are at higher risk of developing a devastating side effect ...
Mar 16, 2023
0
144
